Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Debt to Equity (2021 - 2024)

Biofrontera has reported Debt to Equity over the past 4 years, most recently at $0.03 for Q2 2024.

  • Quarterly results put Debt to Equity at $0.03 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was $0.03 (changed N/A YoY), and the annual figure for FY2023 was $0.81, up 180.17%.
  • Debt to Equity for Q2 2024 was $0.03 at Biofrontera, up from -$0.43 in the prior quarter.
  • Over the last five years, Debt to Equity for BFRIW hit a ceiling of $6.95 in Q3 2023 and a floor of -$0.43 in Q1 2024.
  • Median Debt to Equity over the past 4 years was $0.29 (2021), compared with a mean of $1.06.
  • Biggest five-year swings in Debt to Equity: soared 4741.7% in 2023 and later crashed 203.58% in 2024.
  • Biofrontera's Debt to Equity stood at $0.29 in 2021, then grew by 1.67% to $0.29 in 2022, then skyrocketed by 180.17% to $0.81 in 2023, then plummeted by 96.67% to $0.03 in 2024.
  • The last three reported values for Debt to Equity were $0.03 (Q2 2024), -$0.43 (Q1 2024), and $0.81 (Q4 2023) per Business Quant data.